CHRS logo

Coherus BioSciences (CHRS) Company Overview

Profile

Full Name:

Coherus BioSciences, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

November 6, 2014

Indexes:

Not included

Description:

Coherus BioSciences is a biotechnology company focused on developing and commercializing innovative biosimilar medicines. They aim to provide affordable treatment options for patients by creating high-quality alternatives to expensive biologic drugs, improving access to essential therapies in various therapeutic areas.

Key Details

Price

$1.13

Annual Revenue

$257.24 M(+21.89% YoY)

Annual EPS

-$2.53(+32.71% YoY)

Annual ROE

122.99%

Beta

2.04

Events Calendar

Earnings

Next earnings date:

Mar 13, 2025

Recent quarterly earnings:

Nov 6, 2024

Recent annual earnings:

Mar 13, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 23, 25 HC Wainwright & Co.
Buy
Jan 22, 25 HC Wainwright & Co.
Buy
Dec 5, 24 Baird
Outperform
Dec 4, 24 HC Wainwright & Co.
Buy
Nov 8, 24 Baird
Outperform
Nov 7, 24 HC Wainwright & Co.
Buy
Sep 16, 24 HC Wainwright & Co.
Buy
Aug 16, 24 UBS
Neutral
Aug 5, 24 HC Wainwright & Co.
Buy
Jul 1, 24 Baird
Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Coherus BioSciences?
  • Does Coherus BioSciences pay dividends?
  • What sector is Coherus BioSciences in?
  • What industry is Coherus BioSciences in?
  • What country is Coherus BioSciences based in?
  • When did Coherus BioSciences go public?
  • Is Coherus BioSciences in the S&P 500?
  • Is Coherus BioSciences in the NASDAQ 100?
  • Is Coherus BioSciences in the Dow Jones?
  • When was Coherus BioSciences's last earnings report?
  • When does Coherus BioSciences report earnings?
  • Should I buy Coherus BioSciences stock now?

What is the ticker symbol for Coherus BioSciences?

The ticker symbol for Coherus BioSciences is NASDAQ:CHRS

Does Coherus BioSciences pay dividends?

No, Coherus BioSciences does not pay dividends

What sector is Coherus BioSciences in?

Coherus BioSciences is in the Healthcare sector

What industry is Coherus BioSciences in?

Coherus BioSciences is in the Biotechnology industry

What country is Coherus BioSciences based in?

Coherus BioSciences is headquartered in United States

When did Coherus BioSciences go public?

Coherus BioSciences's initial public offering (IPO) was on November 6, 2014

Is Coherus BioSciences in the S&P 500?

No, Coherus BioSciences is not included in the S&P 500 index

Is Coherus BioSciences in the NASDAQ 100?

No, Coherus BioSciences is not included in the NASDAQ 100 index

Is Coherus BioSciences in the Dow Jones?

No, Coherus BioSciences is not included in the Dow Jones index

When was Coherus BioSciences's last earnings report?

Coherus BioSciences's most recent earnings report was on Nov 6, 2024

When does Coherus BioSciences report earnings?

The next expected earnings date for Coherus BioSciences is Mar 13, 2025

Should I buy Coherus BioSciences stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions